Crescendo Biologics
Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.
4
Funding Rounds
$166.8m
Money raised
Funding
Funding series
Funding Series Analysis
The company Crescendo Biologics has raised a total of $77.3m in funding over 4 rounds.
Key Insights:
- Crescendo Biologics Series B round, April 2018: $70m
- Crescendo Biologics Series A round: $7.3m
- Crescendo Biologics Ltd funding round, May 2018: $70m
- Crescendo Biologics Series A round April 2014: $19.5m
Crescendo Biologics Series B round, April 2018
$70m
Crescendo Biologics Series A round
$7.3m
Crescendo Biologics Ltd funding round, May 2018
$70m
Crescendo Biologics Series A round April 2014
$19.5m
Industries
Crescendo Biologics is active in the following industries: